Les publications

Page en cours de mise à jour... Retrouvez ici les publications des équipes de recherche du CGO

413 publications
Année de publication :
Réseaux :

Management of image guidance doses delivered during radiotherapy.

Image-guided radiotherapy (IGRT) has become a standard irradiation technique to improve the clinical outcome of patients in terms of toxicity and local control due to better targeting of radiation during the irradiation fraction. Positioning imaging systems, whether embedded or not, such as kV for 2×2D acquisitions and especially kVCBCT for 3D acquisitions are however irradiating in a large volume including the target volume but also healthy tissue, with a theoretical risk of increased toxicity and second cancer.

  • Ref: Cancer Radiother. 2020 Dec 31:S1278-3218(20)30324-3.
  • Année de publication : 2020
  • Auteurs : Delpon G, Lazaro D, de Crevoisier R.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer.

(Chemo)-radiotherapy (RT) is the gold standard treatment for patients with locally advanced lung cancer non accessible for surgery. However, current toxicity prediction models rely on clinical and dose volume histograms (DVHs) and remain unsufficient.

  • Ref: Radiother Oncol. 2020 Nov 6;155:144-150.
  • Année de publication : 2020
  • Auteurs : Bourbonne V, Da-Ano R, Jaouen V, Lucia F, Dissaux G, Bert J, Pradier O, Visvikis D, Hatt M, Schick U.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.

Purpose: The aim of this study was to compare retrospectively 18F-DOPA PET/CT versus 68Ga-DOTANOC PET/CT in a group of patients affected by midgut NET.

Patients and methods: Patients with histologically proven grade 1 or grade 2 midgut NET were explored after injection of 150 MBq of 68Ga-DOTANOC and 210 MBq of 18F-DOPA. The PET/CTs were analyzed visually and semiquantitatively at the patient level, regional level (7 defined regions), and lesion level (maximum of 5 lesions/organ).

  • Ref: Clin Nucl Med. 2020 Dec 7.
  • Année de publication : 2020
  • Auteurs : Ansquer C, Touchefeu Y, Faivre-Chauvet A, Leux C, Le Bras M, Régenet N, Fleury V, Maucherat B, Senellart H, Guyetant S, Carlier T, Scotet-Cérato E, Rauscher A, Frampas E, Kraeber-Bodéré F.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Activity of the human immortalized endothelial progenitor cell line HEPC-CB.1 supporting in vitro angiogenesis.

The human HEPC-CB.1 cell line with many characteristics of endothelial progenitor cells (EPC) was tested for its proangiogenic properties as a potentially therapeutic compound. HEPC-CB.1 cells’ potential to differentiate into endothelial cells was revealed after treating the cells with a mixture of ATRA, cAMP and VEGF, as shown by the reduced expression levels of CD133, CD271 and CD90 antigens, augmentation of CD146 and CD31, and a decrease in cell clonogenicity.

  • Ref: doi: 10.1007/s11033-020-05662-6.
  • Année de publication : 2020
  • Auteurs : Kantor A, Krawczenko A, Bielawska-Pohl A, Duś D, Grillon C, Kieda C, Charkiewicz K, Paprocka M
  • Réseaux : Réseaux: « Immunothérapies » & « Niches et Epigénétique des Tumeurs »
Lire la publication

Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological…

Background: Targeted therapies such as BRAF and MEK inhibitors and immunotherapies have been made available to treat melanoma.

Objectives: To provide an overview of the management of the French Stage III melanoma population after complete lymph node resection prior to new adjuvant therapies.

  • Ref: doi: 10.1684/ejd.2020.3848.
  • Année de publication : 2020
  • Auteurs : Dalle S, Varey E, Nguyen JM, Dupuy A, Montaudie H, Lesage C, Mortier L, Leccia MT, Skowron F, Celerier P, Meyer N, Dutriaux C, Dalac-Rat S, Khammari A, Lebbe C, Dréno B.
  • Réseaux : Réseaux: « Immunothérapies » & « Hub Oncologie 4.0
Lire la publication

Biocompatibility and osseointegration of nanostructured titanium dental implants in minipigs

Reconstructing large bone defects caused by severe trauma or resection of tumors remains a challenge for surgeons. A fibula free flap and its vascularized bed can be transplanted to the reconstruction site to achieve healing. However, this technique adds morbidity, and requires microsurgery and sculpting of the bone tissue to adapt the graft to both the vasculature and the anatomy of the defect.

  • Ref: doi: 10.1111/clr.13589.
  • Année de publication : 2020
  • Auteurs : Hoornaert A, Vidal L, Besnier R, Morlock JF, Louarn G, Layrolle P.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies » & « Cancers des Tissus Hormono-dépendants »
Lire la publication

Biomarkers of tumor invasiveness in proteomics (Review).

Over the past two decades, quantitative proteomics has emerged as an important tool for deciphering the complex molecular events involved in cancers. The number of references involving studies on the cancer metastatic process has doubled since 2010, while the last 5 years have seen the development of novel technologies combining deep proteome coverage capabilities with quantitative consistency and accuracy.

  • Ref: doi: 10.3892/ijo.2020.5075
  • Année de publication : 2020
  • Auteurs : Pouliquen DL, Boissard A, Coqueret O, Guette C.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs » & « Cancers des Tissus Hormono-dépendants »
Lire la publication

Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors.

Despite research and clinical advances during recent decades, bone cancers remain a leading cause of death worldwide. There is a low survival rate for patients with primary bone tumors such as osteosarcoma and Ewing’s sarcoma or secondary bone tumors such as bone metastases from prostate carcinoma.

  • Ref: doi: 10.3390/biom10091240
  • Année de publication : 2020
  • Auteurs : Talbot J, Dupuy M, Morice S, Rédini F, Verrecchia F.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs » & « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative…

This prospective study evaluated the imaging performance of a novel pretargeting immunologic PET (immuno-PET) method in patients with human epidermal growth factor receptor 2 (HER2)-negative, carcinoembryonic antigen (CEA)-positive metastatic breast cancer, compared with CT…

  • Ref: doi: 10.2967/jnumed.119.236000
  • Année de publication : 2020
  • Auteurs : Rousseau C, Goldenberg DM, Colombié M, Sébille JC, Meingan P, Ferrer L, Baumgartner P, Cerato E, Masson D, Campone M, Rauscher A, Fleury V, Labbe C, Chauvet AF, Fresnel JS, Toquet C, Barbet J, Sharkey RM, Campion L, Kraeber-Bodéré F.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies » & « Cancers des Tissus Hormono-dépendants »
Lire la publication